Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients

Background: The use of (18)F-2-Fluor-2-desoxy-D-glucose Positron Emission Tomography/Computed Tomography FDG-PET/CT in clinical routine for staging, treatment response monitoring and post treatment surveillance in metastatic melanoma patients has noticeably increased due to significant improvement o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudura, Ken, Dimitriou, Florentia, Mihic-Probst, Daniela, Muehlematter, Urs J., Kutzker, Tim, Basler, Lucas, Förster, Robert, Dummer, Reinhard, Mangana, Joanna, Husmann, Lars, Burger, Irene A., Kreissl, Michael Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156636/
https://www.ncbi.nlm.nih.gov/pubmed/34063555
http://dx.doi.org/10.3390/diagnostics11050883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156636/
https://www.ncbi.nlm.nih.gov/pubmed/34063555
http://dx.doi.org/10.3390/diagnostics11050883

Ejemplares similares